SCHEMBL5740905

SCHEMBL5740905

O=c1c2ccncc2nc2n1CCc1c-2[nH]c2ccccc12

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 15/20 0.78
CYP1B1 Q16678 15/20 0.78
CYP1A2 P05177 14/20 0.78
PDE5A O76074 4/20 0.78
KDM4E B2RXH2 2/20 0.78
NPC1 O15118 2/20 0.78
ALDH1A1 P00352 2/20 0.78
TP53 P04637 2/20 0.78
POLB P06746 2/20 0.78
RAB9A P51151 2/20 0.78
SMN1; SMN2 Q16637 2/20 0.78
LMNA P02545 1/20 0.78
CYP3A4 P08684 1/20 0.78
PKM P14618 1/20 0.78
TSHR P16473 1/20 0.78
PTGS1 P23219 1/20 0.78
PTGS2 P35354 1/20 0.78
THPO P40225 1/20 0.78
MTOR P42345 1/20 0.78
BLM P54132 1/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rutaecarpine SCHEMBL29693598 0.88 CYP1A1 (1.00) CYP1A1CYP1B1CYP1A2PDE5AKDM4E
Rutaecarpine SCHEMBL288507 0.88 CYP1A1 (1.00) CYP1A1CYP1B1CYP1A2PDE5AKDM4E
Rutaecarpine SCHEMBL29406533 0.88 CYP1A1 (1.00) CYP1A1CYP1B1CYP1A2PDE5AKDM4E
SCHEMBL15500023 0.81 CYP1A1 (0.76) CYP1A1CYP1B1CYP1A2PDE5AKDM4E
SCHEMBL14297679 0.81 CYP1A1 (1.00) CYP1A1CYP1B1CYP1A2PDE5AKDM4E
SCHEMBL25150530 0.79 CYP1A1 (0.78) CYP1A1CYP1B1CYP1A2PDE5AKDM4E
SCHEMBL30268975 0.78 BCHE (0.70) CYP1A1CYP1B1CYP1A2PDE5AKDM4E
SCHEMBL25219690 0.78 BCHE (0.70) CYP1A1CYP1B1CYP1A2PDE5AKDM4E
SCHEMBL14316571 0.77 CYP1A1 (0.70) CYP1A1CYP1B1CYP1A2PDE5AKDM4E
SCHEMBL11047610 0.77 CYP1A1 (0.78) CYP1A1CYP1B1CYP1A2PDE5AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397361-B1 CARBOLINE DERIVATIVES AS PDEV INHIBITORS LILLY ICOS LLC (US) 2006-08-09 EP disclosed
US-6984641-B2 Carboline derivatives as PDE5 inhibitors LILLY ICOS LLC. (US) 2006-01-10 US disclosed
US-20040171830-A1 Carboline derivatives as pdev inhibitors LILLY ICOS LLC 2004-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171830-A1 Carboline derivatives as pdev inhibitors PDE3B, PDE3A, PDE2A CYP1A1 2658/4885CYP1B1 2386/4885CYP1A2 1785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.